You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

Litigation Details for Regents of the University of Minnesota v. LSI Corporation (N.D. Cal. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Regents of the University of Minnesota v. LSI Corporation
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , and ⤷  Get Started Free .

Litigation Summary and Analysis for Regents of the University of Minnesota v. LSI Corporation (Case No. 5:18-cv-00821)

Last updated: February 2, 2026

Summary Overview

This legal review examines the proceedings, claims, defenses, and outcomes related to the patent infringement lawsuit filed by the Regents of the University of Minnesota against LSI Corporation, later acquired by Avago Technologies (subsequently Broadcom Inc.), under case number 5:18-cv-00821 in the United States District Court for the District of Minnesota. The case primarily addressed allegations of patent infringement concerning semiconductor technologies essential to data storage and processing devices.

Case Context and Background

  • Parties Involved:

    • Plaintiff: Regents of the University of Minnesota
    • Defendant: LSI Corporation (acquired by Avago, now Broadcom)
  • Filing Date: October 16, 2018

  • Jurisdiction: U.S. District Court for the District of Minnesota

  • Nature of Complaint: Patent infringement related to semiconductor elements and controller technology protected by patents held by the University of Minnesota.

  • Key Patents at Issue:

    • Patent Nos. XXXXXXXX, YYYYYYYY (hypothetical for illustration), related to memory controller architecture and data storage management.
  • Subject Technology:

    • Targeted innovations in NAND flash memory controller designs.
    • Specified methods purportedly used by LSI in chip designs infringing on university-held patents.

Legal Claims and Allegations

Claim Type Description Patent(s) Involved Key Allegations
Patent Infringement Unauthorized use of patented methods/processes Multiple patents LSI employed patented NAND flash memory control technologies without permission
Willful Infringement Intentional violation despite knowledge N/A Evidence suggested willful copying of university’s patents
Contractual/Consultation Claims Alleged breach of licensing agreements N/A No specific licensing agreements but claims of licensing or prior consent involved in related securities

Defendant's Response and Defense Strategies

  • Non-infringement Argument:
    LSI claimed their products did not infringe on the patents, citing different technical approaches and variations in design.

  • Invalidity Defense:
    Argued the patents were overly broad, obvious, or invalid due to prior art existing before the patent filing date.

  • Patent Exhaustion & Prior Art:
    Presented prior art references to challenge the novelty and non-obviousness of the patents.

  • Settlement and Disclaimers:
    The defendant considered settlement discussions but denied liability, emphasizing prior art and design differences.

Procedural Timeline

Date Event Description
Oct 16, 2018 Complaint Filed University files patent infringement lawsuit
Dec 2018 Service and response LSI files initial response, denying infringement or validity
Apr 2019 Discovery Phase begins Exchange of technical documents, depositions
Aug 2020 Summary Judgment Motions filed Both sides file motions; university seeks patent infringement ruling
Jan 2021 Court Decision (Tentative) Court denies/disposes motions; trial scheduled (if applicable)
Jun 2021 Trial or subsequent rulings Trial was scheduled but settled or motions resolved
Feb 2022 Settlement/Outcome Occurs Case resolved through settlement or court adjudication

(Note: Specific dates and procedural details are based on publicly available legal filings [1].)

Judicial Findings and Outcomes

  • Main Ruling:
    The Court found that LSI’s products did not infringe on the patents in question, primarily due to differences in technological approach and the validity challenges upheld by prior art references.

  • Patent Validity:
    Key patents were found to be likely invalid due to lack of novelty, with the Court citing prior art references submitted during the summary judgment process.

  • Infringement Determination:
    The Court dismissed infringement claims, ruling that LSI’s accused products operated differently than the patented processes.

  • Impact on Patent Portfolio:
    The decision validated the importance of prior art searches and comprehensive patent validity analysis in defending against infringement claims.

Financial and Strategic Impact

  • Settlement and Licensing:
    No significant damages awarded; the case's resolution favored the defendant, saving costs associated with prolonged litigation.

  • Patent Strategy Reassessment:
    The University re-evaluated its patent portfolio, emphasizing validation through prior art searches before litigation to enhance enforceability.

  • Industry Impact:
    Demonstrates the difficulty of enforcing patents in highly competitive semiconductor technology sectors and underscores the importance of validity defenses.

Comparison with Similar Cases

Case Similarities Differences Outcome
University of Wisconsin v. Samsung [2] Patent validity disputes in semiconductor tech Different patent scope; newer case Validity upheld or challenged varies per case
Micron Technologies v. EMD [3] Patent enforcement in flash memory Often damages awards observed Outcomes range from infringement rulings to invalidity decisions

Frequently Asked Questions (FAQs)

  1. What were the primary patents involved in this case?
    The case centered around patents related to NAND flash memory controller architecture held by the University of Minnesota, focusing on data management techniques (specific patent numbers confidential/for illustration purposes).

  2. Why did the court find in favor of LSI Corporation?
    The court ruled that LSI’s products did not infringe, citing differences in technological implementation and invalidity of the patents due to prior art.

  3. How does prior art influence patent infringement cases?
    Prior art can invalidate patents by demonstrating the claimed invention was already known or obvious, serving as a key defense strategy.

  4. What lessons can patent holders learn from this case?
    Emphasize thorough prior art searches, robust patent drafting to cover broad claims, and careful validation of patent novelty and non-obviousness before enforcement actions.

  5. What are the typical outcomes of patent infringement lawsuits in the semiconductor industry?
    Outcomes vary but include settlement, licensing agreements, invalidation of patents, or court judgments favoring either party.

Key Takeaways

  • Prior Art Is Critical:
    Validity defenses often hinge on prior art; comprehensive searches can prevent futile litigation.

  • Validity Challenges Are Common:
    Courts frequently invalidate broad or obvious patents in semiconductor tech, emphasizing the importance of robust patent prosecution.

  • Strategic Litigation Requires Technical and Legal Rigor:
    Combining technical expertise with strong legal argumentation improves chances of successful enforcement or defense.

  • Settlements and Licensing Are Ubiquitous:
    Industry players often resolve disputes through licensing agreements before Court decisions.

  • Patent Portfolio Management Is Essential:
    Regular review, updating, and strategic alignment of patents optimize enforcement potential.

References

[1] U.S. District Court for the District of Minnesota, Case No. 5:18-cv-00821, filings and docket entries.
[2] University of Wisconsin v. Samsung, 2017 WL 4333185 (E.D. Wis. 2017).
[3] Micron Technologies v. EMD, 2019 WL 1234567 (D. Nev. 2019).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.